Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cel Sci Corp (CVM)  
$1.56 0.06 (4%) as of 4:30 Fri 4/19


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 38,620,000
Market Cap: 60.25(M)
Last Volume: 2,036,333 Avg Vol: 2,030,624
52 Week Range: $1.07 - $3.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CEL-SCI is a clinical-stage biotechnology company focused on research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. Co. is focused on the development of the following product candidates and technologies: Multikine® (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the potential treatment of certain head and neck cancers; and Ligand Epitope Antigen Presentation System technology, with CEL-4000 as a product candidate under development for the potential treatment of rheumatoid arthritis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 227
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Prichep Patricia B Senior Vice President   •       –      –    2024-03-29 4 A $1.91 $4,290 D/D 2,246 224,326     -
   Talor Eyal Chief Scientific Officer   •       –      –    2024-03-29 4 A $1.91 $2,399 D/D 1,256 114,264     -
   Kersten Geert R Chief Executive Officer   •       •      –    2024-03-29 4 A $1.91 $5,174 D/D 2,709 1,165,309     -
   Talor Eyal Chief Scientific Officer   •       –      –    2023-12-29 4 A $2.72 $2,399 D/D 882 113,008     -
   Kersten Geert R Chief Executive Officer   •       •      –    2023-12-29 4 A $2.72 $4,948 D/D 1,819 1,162,600     -
   Prichep Patricia B Senior Vice President   •       –      –    2023-12-29 4 A $2.72 $4,289 D/D 1,577 222,080     -
   Talor Eyal Chief Scientific Officer   •       –      –    2023-09-29 4 A $1.25 $2,400 D/D 1,920 112,126     -
   Prichep Patricia B Senior Vice President   •       –      –    2023-09-29 4 A $1.25 $4,290 D/D 3,432 220,503     -
   Kersten Geert R Chief Executive Officer   •       •      –    2023-09-29 4 A $1.25 $4,950 D/D 3,960 1,160,781     -
   Prichep Patricia B Senior Vice President   •       –      –    2023-06-30 4 A $2.41 $4,290 D/D 1,780 217,071     -
   Talor Eyal Chief Scientific Officer   •       –      –    2023-06-30 4 A $2.41 $2,398 D/D 995 110,206     -
   Kersten Geert R Chief Executive Officer   •       •      –    2023-06-30 4 A $2.41 $4,948 D/D 2,053 1,156,821     -
   Prichep Patricia B Senior Vice President   •       –      –    2023-03-31 4 A $2.32 $4,290 D/D 1,849 215,291     -
   Kersten Geert R Chief Executive Officer   •       •      –    2023-03-31 4 A $2.32 $4,949 D/D 2,133 1,154,768     -
   Talor Eyal Chief Scientific Officer   •       –      –    2023-03-31 4 A $2.32 $2,399 D/D 1,034 109,211     -
   Kersten Geert R Chief Executive Officer   •       •      –    2022-12-30 4 A $2.35 $4,350 D/D 1,851 1,152,635     -
   Prichep Patricia B Senior Vice President   •       –      –    2022-12-30 4 A $2.35 $4,289 D/D 1,825 213,442     -
   Talor Eyal Chief Scientific Officer   •       –      –    2022-12-30 4 A $2.35 $2,399 D/D 1,021 108,177     -
   Kersten Geert R Chief Executive Officer   •       •      –    2022-09-30 4 A $3.09 $4,348 D/D 1,407 1,150,784     -
   Prichep Patricia B Senior Vice President   •       –      –    2022-09-30 4 A $3.09 $4,289 D/D 1,388 211,617     -
   Talor Eyal Chief Scientific Officer   •       –      –    2022-09-30 4 A $3.09 $2,398 D/D 776 107,156     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2022-09-30 4 A $3.09 $3,912 D/D 1,266 120,226     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2022-06-30 4 A $4.50 $3,942 D/D 876 118,960     -
   Prichep Patricia B Senior Vice President   •       –      –    2022-06-30 4 A $4.50 $4,289 D/D 953 210,229     -
   Talor Eyal Chief Scientific Officer   •       –      –    2022-06-30 4 A $4.50 $2,399 D/D 533 106,380     -

  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed